, , , , , , , , , , ,

As mentioned on this evening’s ‘This Week in Oncology broadcast, we discussed the hearings that began today in Washington DC regarding the FDA’s

plan to revoke the accelerated market approval of Avastin for the treatment of late stage breast cancer.

Day 2 is tomorrow, June 29th, 2011 and the hearing is open to the public, however you must register in order to watch the live web cast. You may do so by clicking here.

We’ll continue to follow this impassioned story. For additional context see the Wall Street Journal blog story ‘FDA Appeals Panel to Hold Avastin Hearing This Week‘ and the op-ed piece tracking the ideological prisms spinning the meaning of the hearing in the Los Angeles Times: Avastin: There’s the truth and then there’s the politics behind the cancer drug.